Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Short-term Investments (2021 - 2025)

Trulieve Cannabis has reported Short-term Investments over the past 4 years, most recently at $907000.0 for Q4 2024.

  • For Q4 2024, Short-term Investments fell 86.27% year-over-year to $907000.0; the TTM value through Dec 2024 reached $907000.0, down 86.27%, while the annual FY2024 figure was $907000.0, 86.27% down from the prior year.
  • Short-term Investments for Q4 2024 was $907000.0 at Trulieve Cannabis, roughly flat from $907000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $14.5 million in Q4 2022 and troughed at $907000.0 in Q3 2024.
  • A 4-year average of $6.9 million and a median of $7.7 million in 2021 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: soared 66.54% in 2022 and later tumbled 86.27% in 2024.
  • Year by year, Short-term Investments stood at $8.7 million in 2021, then soared by 66.54% to $14.5 million in 2022, then plummeted by 54.5% to $6.6 million in 2023, then tumbled by 86.27% to $907000.0 in 2024.
  • Business Quant data shows Short-term Investments for TCNNF at $907000.0 in Q4 2024, $907000.0 in Q3 2024, and $6.6 million in Q4 2023.